ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

Fisher, Redmond Removed Fro Official posts At NSABP

May 13, 1994

Tobacco Use Research Centers Funded

October 22, 1999

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

NCI CTEP-Approved Trials For the Month of March

March 28, 2014